Cargando…

Update on the treatment of metastatic renal cell carcinoma

Metastatic renal cell cancer (mRCC) management has undergone a paradigm shift in recent decades. The first revolution came with the emergence of vascular endothelial growth factor inhibitors; there was a second wave with the unprecedented success of checkpoint inhibitors, and then the latest approac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medina López, Rafael Antonio, Rivero Belenchon, Ines, Mazuecos-Quirós, Javier, Congregado-Ruíz, Carmen Belén, Couñago, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790301/ https://www.ncbi.nlm.nih.gov/pubmed/35116228 http://dx.doi.org/10.5306/wjco.v13.i1.1

Ejemplares similares

Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
por: Congregado Ruiz, Belén, et al.
Publicado: (2023)

Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)
por: Rivero Belenchón, Inés, et al.
Publicado: (2023)

PARP Inhibitors: A New Horizon for Patients with Prostate Cancer
por: Congregado, Belén, et al.
Publicado: (2022)

Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
por: Gajate, Pablo, et al.
Publicado: (2020)

Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)

COVID-19 and information and communication technology in radiation oncology: A new paradigm
por: Fernández, Castalia, et al.
Publicado: (2020)

Targeted Therapy for Metastatic Renal Carcinoma: an Update
por: da Silva, Rodrigo Donalisio, et al.
Publicado: (2014)

Are all prostate cancer patients "fit" for salvage radiotherapy?
por: González-San Segundo, Carmen, et al.
Publicado: (2020)

Updating Clear Cell Renal Cell Carcinoma (a Tribute to Prof. Ondrej Hes)
por: Manini, Claudia, et al.
Publicado: (2022)

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Routine Bone Imaging for Metastatic Renal Cell Carcinoma: Is it Time?
por: Parikh, Mamta
Publicado: (2021)

Comparative analysis of short - term functional outcomes and quality of life in a prospective series of brachytherapy and Da Vinci robotic prostatectomy
por: García-Sánchez, Cristina, et al.
Publicado: (2017)

Updates in renal pathology
por: Jeong, Hyeon Joo
Publicado: (2023)

New standard in locally advanced rectal cancer
por: Solé, Sebastián, et al.
Publicado: (2020)

Feasibility and safety of surgical wound remote follow-up by smart phone in appendectomy: A pilot study
por: Segura-Sampedro, Juan José, et al.
Publicado: (2017)

Updates in Clinical and Translational Glaucoma Research
por: García-Medina, José Javier, et al.
Publicado: (2021)

Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities
por: Graves, Angela, et al.
Publicado: (2013)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma
por: Bourlon, Maria T., et al.
Publicado: (2023)

Renal transplantation: An update
por: Srivastava, Aneesh
Publicado: (2007)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
por: Barros, José Máximo, et al.
Publicado: (2021)

Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
por: Henriquez, Ivan, et al.
Publicado: (2021)

The Labyrinth of Renal Cell Carcinoma
por: Manini, Claudia, et al.
Publicado: (2020)

Gene expression profiles and treatments for metastatic renal cell carcinoma: What does still need to be defined?
por: Giunta, Emilio F., et al.
Publicado: (2022)

New prognostic models in metastatic renal cancer
por: Lim, Louise, et al.
Publicado: (2012)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Update on the Treatment of Metastatic Urothelial Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2018)

Merkel Cell Carcinoma: An Update and Review
por: Stockfleth, Eggert
Publicado: (2023)

Artificial intelligence for renal cancer: From imaging to histology and beyond
por: Kowalewski, Karl-Friedrich, et al.
Publicado: (2022)

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
por: Santoni, Matteo, et al.
Publicado: (2018)

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment
por: Chara, Luis, et al.
Publicado: (2011)

Deficit sustainability and fiscal theory of price level: the case of Italy, 1861–2020
por: Congregado, Emilio, et al.
Publicado: (2023)

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
por: Martínez-Chantar, Maria L., et al.
Publicado: (2020)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

Challenging Glaucomas: Update on Diagnosis and Management
por: Scuderi, Gianluca, et al.
Publicado: (2016)

Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma
por: Algarra, Maria Asunción, et al.
Publicado: (2020)

Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies
por: Martin, Margarita, et al.
Publicado: (2022)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Referee
por: Minervini, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3i4sbm2t091lk0qjg15h5kjenb